Reconstructive Transplantation and Regenerative Medicine
The Emerging Interface
Series: Gene and Cell Therapy;
- Publisher's listprice GBP 48.99
-
24 793 Ft (23 613 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 2 479 Ft off)
- Discounted price 22 314 Ft (21 252 Ft + 5% VAT)
24 793 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 1
- Publisher CRC Press
- Date of Publication 29 January 2024
- ISBN 9781032116761
- Binding Paperback
- No. of pages223 pages
- Size 234x156 mm
- Weight 376 g
- Language English
- Illustrations 2 Illustrations, black & white; 28 Illustrations, color; 1 Halftones, black & white; 11 Halftones, color; 1 Line drawings, black & white; 17 Line drawings, color; 7 Tables, black & white; 1 Tables, color 583
Categories
Short description:
This book summarizes rapid progress and innovation in transplantation and regenerative medicine - the merger of reconstructive plastic surgery and transplantation - called Vascularized Composite Allotransplantation. This merger includes a wide variety of previously impossible translplantations using grafts derived from organ donors.
MoreLong description:
This book summarizes rapid progress and innovation in transplantation and regenerative medicine - the merger of reconstructive plastic surgery and transplantation - called Vascularized Composite Allotransplantation. This merger includes face, hand, uteri, larynx, tongue, penis and trachea translplantations as well as other body part transplants using grafts derived from organ donors. These sorts of transplants are now performed more commonly. Cell therapies for immunomodulation are surrogates for immune responses after transplantation to non-invasive imaging of neuroregeneration for improving functional outcomes after transplant.
MoreTable of Contents:
Contributors. CELLULAR THERAPIES IN RECONSTRUCTIVE TRANSPLANTATION. Cell Therapies in Reconstructive Transplantation. Novel T-Regulatory Cell-Based Therapies in Vascularized Composite Allotransplantation: Translational Implications. UNIQUE CONSIDERATIONS AND EMERGING INDICATIONS IN RECONSTRUCTIVE TRANSPLANTATION. Invasive and Non-Invasive Surrogates for Chronic Rejection in Vascularized Composite Allotransplantation: Claims and Controversies. Reperfusion Injury in Vascularized Composite Tissue Allografts: Impact on Graft Outcomes and Preventive Strategies. Pediatric Upper Extremity Vascularized Composite Allotransplantation: Progress and Insights. GRAFT MONITORING IN RECONSTRUCTIVE TRANSPLANTATION. Targeted Imaging and Therapeutic Technologies in Neuroregeneration. Biomarkers and Surrogates of Acute Rejection in Vascularized Composite Allograft Transplantation. COMPOSITE TISSUE GRAFT MANIPULATION AND ENGINEERING. Bioengineering Composite Tissue Constructs: Concepts and Challenges. Advances in Biomaterials for Reconstructive Transplantation. Gene Editing Strategies for Immunomodulation: Translation from Cells to Vascularized Tissues. Index.
More
